Janus Global Life Sciences Fund

Scorecard
4 / 5 Stars
Lipper
5 5 5 5 3
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
4 / 5 Stars
TheStreet.com
A- (Buy)

Fund Holdings

Asset Allocation

% Long % Net
Cash 1.26 1.26
Stocks 68.36 68.36
Bonds 0.0 0.0
Other 2.06 2.06
Foreign Bonds 0.0 0.0
Foreign Stocks 27.22 27.22
Convertible 1.1 1.1
Preferred 0.0 0.0

Updated 03.31.2014

Top 10 Holdings

Performance as of 06.30.2014

Portfolio as of 03.31.2014

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD 13.57 4.5
Aetna Inc AET 20.29 2.87
Express Scripts ESRX -1.67 2.83
Johnson & Johnson JNJ 17.08 2.75
Celgene Corp CELG 4.75 2.68
Biogen Idec Inc BIIB 16.16 2.61
Roche Holding AG RHHVF 8.87 2.3
Valeant Pharmaceuticals International Inc VRX 6.97 2.19
AstraZeneca PLC ADR AZN 29.19 1.78
NPS Pharmaceuticals Inc NPSP 8.33 1.74